These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 14608894)
1. GLUT1 messenger RNA and protein induction relates to the malignant transformation of cervical cancer. Rudlowski C; Becker AJ; Schroder W; Rath W; Büttner R; Moser M Am J Clin Pathol; 2003 Nov; 120(5):691-8. PubMed ID: 14608894 [TBL] [Abstract][Full Text] [Related]
2. GLUT1 mRNA and protein expression in ovarian borderline tumors and cancer. Rudlowski C; Moser M; Becker AJ; Rath W; Buttner R; Schroder W; Schurmann A Oncology; 2004; 66(5):404-10. PubMed ID: 15331928 [TBL] [Abstract][Full Text] [Related]
3. Expression of facilitative glucose transporters in gastric tumors. Noguchi Y; Marat D; Saito A; Yoshikawa T; Doi C; Fukuzawa K; Tsuburaya A; Satoh S; Ito T Hepatogastroenterology; 1999; 46(28):2683-9. PubMed ID: 10522065 [TBL] [Abstract][Full Text] [Related]
4. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer. Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681 [TBL] [Abstract][Full Text] [Related]
5. The relationship between c-FLIP expression and human papillomavirus E2 gene disruption in cervical carcinogenesis. Wang W; Wang S; Song X; Sima N; Xu X; Luo A; Chen G; Deng D; Xu Q; Meng L; Lu Y; Ma D Gynecol Oncol; 2007 Jun; 105(3):571-7. PubMed ID: 17433827 [TBL] [Abstract][Full Text] [Related]
6. Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer. Branca M; Ciotti M; Santini D; Bonito LD; Benedetto A; Giorgi C; Paba P; Favalli C; Costa S; Agarossi A; Alderisio M; Syrjänen K; Am J Clin Pathol; 2004 Dec; 122(6):902-11. PubMed ID: 15539382 [TBL] [Abstract][Full Text] [Related]
8. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases. Younes M; Lechago LV; Lechago J Clin Cancer Res; 1996 Jul; 2(7):1151-4. PubMed ID: 9816281 [TBL] [Abstract][Full Text] [Related]
10. Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening. Ekalaksananan T; Pientong C; Sriamporn S; Kongyingyoes B; Pengsa P; Kleebkaow P; Kritpetcharat O; Parkin DM Gynecol Oncol; 2006 Oct; 103(1):62-6. PubMed ID: 16494930 [TBL] [Abstract][Full Text] [Related]
11. Gene identification by cDNA arrays in HPV-positive cervical cancer. Vázquez-Ortíz G; Ciudad CJ; Piña P; Vazquez K; Hidalgo A; Alatorre B; Garcia JA; Salamanca F; Peralta-Rodriguez R; Rangel A; Salcedo M Arch Med Res; 2005; 36(5):448-58. PubMed ID: 16099320 [TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection. Pientong C; Ekalaksananan T; Kongyingyoes B; Kritpetcharat O; Swadpanich U; Pengsa P; Yuenyao P Diagn Cytopathol; 2004 Oct; 31(4):235-42. PubMed ID: 15452898 [TBL] [Abstract][Full Text] [Related]
13. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials. Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254 [TBL] [Abstract][Full Text] [Related]
14. p16 expression in the female genital tract and its value in diagnosis. O'Neill CJ; McCluggage WG Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152 [TBL] [Abstract][Full Text] [Related]
15. Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues. Godoy A; Ulloa V; Rodríguez F; Reinicke K; Yañez AJ; García Mde L; Medina RA; Carrasco M; Barberis S; Castro T; Martínez F; Koch X; Vera JC; Poblete MT; Figueroa CD; Peruzzo B; Pérez F; Nualart F J Cell Physiol; 2006 Jun; 207(3):614-27. PubMed ID: 16523487 [TBL] [Abstract][Full Text] [Related]
16. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers. Younes M; Lechago LV; Somoano JR; Mosharaf M; Lechago J Cancer Res; 1996 Mar; 56(5):1164-7. PubMed ID: 8640778 [TBL] [Abstract][Full Text] [Related]
17. GLUT1 expression in human breast carcinoma: correlation with known prognostic markers. Younes M; Brown RW; Mody DR; Fernandez L; Laucirica R Anticancer Res; 1995; 15(6B):2895-8. PubMed ID: 8669885 [TBL] [Abstract][Full Text] [Related]
18. Expression of glucose transporter 1 in human endometrial and decidual tissue. Strowitzki T; Capp E; von Wolff M; Müller-Höcker J Gynecol Endocrinol; 2001 Jun; 15(3):219-24. PubMed ID: 11447734 [TBL] [Abstract][Full Text] [Related]
19. Gene expression of glucose transporters and its regulation by glucose in mesothelial cells. Lu C; Ye R; Yang Q; Yang X; Li H; Li Y Chin Med J (Engl); 2001 May; 114(5):477-80. PubMed ID: 11780407 [TBL] [Abstract][Full Text] [Related]
20. Distribution of the glucose transporters in human brain tumors. Nishioka T; Oda Y; Seino Y; Yamamoto T; Inagaki N; Yano H; Imura H; Shigemoto R; Kikuchi H Cancer Res; 1992 Jul; 52(14):3972-9. PubMed ID: 1617673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]